Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Radiofrequency Ablation (RFA) of Renal (kidney) Tumors

Clinical Trials

    • Cancer(4)
  • Kidney Cancer

    The HistoSonics Edison System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY US)

    • Ages22 years and older
    • GenderBoth
  • Kidney Cancer

    Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)

    • Kidney Cancer

      Phase II Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

      • Kidney Cancer, Melanoma

        A Phase 1/2a, Open-Label, Dose-Escalation and Dose-Expansion First-In-Human Study of the Safety, Tolerability, Activity, and Pharmacokinetics of REGN10597 (Anti PD-1-IL2RA-IL2 Fusion Protein) in Patients With Advanced Solid Organ Malignancies

        • About Us
        • Contact Us
        • Donate
        • Referring Doctors
        • Clinical Keywords

        333 Cedar St.

        New Haven, CT 06510

        • Yale School of Medicine
        • Yale University
        • Terms & Privacy Policies
        • Accessibility at YSM
        • Patient Rights
        • HIPAA at Yale
        • Non-discrimination Statement
        Copyright 2025 Yale Medicine